Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers

被引:58
作者
Mutalik, Srinivas [1 ]
Shetty, Pallavi K. [1 ]
Kumar, Aravind [1 ]
Kalra, Rohit [1 ]
Parekh, Harendra S. [2 ]
机构
[1] Manipal Univ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut, Manipal 576104, Karnataka, India
[2] Univ Queensland, Sch Pharm, Pharm Australia Ctr Excellence, Brisbane, Qld, Australia
关键词
5-Fluorouracil; human skin; peptide dendrimers; skin permeation; transdermal; TRANSDERMAL DRUG-DELIVERY; IN-VITRO; POLY(AMIDOAMINE) DENDRIMERS; POLYAMIDOAMINE DENDRIMER; PENETRATION ENHANCERS; SKIN PERMEATION; PAMAM DENDRIMER; IONTOPHORESIS; VIVO; ELECTROPORATION;
D O I
10.3109/10717544.2013.845861
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Enhancing the deposition and permeation of 5-fluorouracil across human epidermis assisted by appropriately charged and well-defined peptide dendrimers was investigated. Peptide dendrimers with arginine as the terminal amino acid and having a range of terminal positive charges (4(+), 8(+) and 16(+)) were synthesized by solid phase peptide synthesis. Various parameters including effect of peptide dendrimers on the solubility and partition coefficient of 5-FU, degradation of drug in skin as well as deposition and permeation of 5-FU in/through skin were studied. All the tested dendrimers increased the aqueous solubility and partition coefficient of 5-FU with each also significantly (p<0.05) enhancing the deposition and permeation of 5-FU in/across human epidermis in a concentration-dependent manner. Of the three peptide dendrimers examined, R8 dendrimer (bearing 8(+) charge derived from four terminal arginines and MW of & approximate to 1000 Da) showed greatest values for flux, Q(48) (cumulative amount of drug permeated at the end of 48 h) and amount of drug retained in human skin. Furthermore, this study also scrutinized and reports on the likely mechanisms by which peptide dendrimers act as transdermal permeation enhancers.
引用
收藏
页码:44 / 54
页数:11
相关论文
共 51 条
[1]   Synthesis and Evaluation of Pegylated Dendrimeric Nanocarrier for Pulmonary Delivery of Low Molecular Weight Heparin [J].
Bai, Shuhua ;
Ahsan, Fakhrul .
PHARMACEUTICAL RESEARCH, 2009, 26 (03) :539-548
[2]   Transdermal delivery of 5-fluorouracil (5-FU) by 1-alkylcarbonyl-5-FU prodrugs [J].
Beall, HD ;
Sloan, KB .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) :203-210
[3]  
Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915
[4]   Effect of polyamidoamine dendrimer G3 and G4 on skin permeation of 8-methoxypsoralene-In vivo study [J].
Borowska, Katarzyna ;
Wolowiec, Stanislaw ;
Rubaj, Andrzej ;
Glowniak, Kazimierz ;
Sieniawska, Elwira ;
Radej, Sebastian .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 426 (1-2) :280-283
[5]  
Chandra A, 2008, AFR J PHARM PHARMACO, V2, P184
[6]   Physicochemical and Pharmacokinetic Parameters in Drug Selection and Loading for Transdermal Drug Delivery [J].
Chandrashekar, N. S. ;
Rani, R. H. Shobha .
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 70 (01) :94-U18
[7]   Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin [J].
Chauhan, AS ;
Sridevi, S ;
Chalasani, KB ;
Jain, AK ;
Jain, SK ;
Jain, NK ;
Diwan, PV .
JOURNAL OF CONTROLLED RELEASE, 2003, 90 (03) :335-343
[8]   Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers [J].
Cheng Yiyun ;
Man Na ;
Xu Tongwen ;
Fu Rongqiang ;
Wang Xueyuan ;
Wang Xiaomin ;
Wen Longping .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (03) :595-602
[9]   Biological applications of dendrimers [J].
Cloninger, MJ .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (06) :742-748
[10]  
da Costa Carla Andreia Miranda, 2003, Acta Scientiarum Technology, V25, P53